Caricamento...
Biomarker testing in MCI patients—deciding who to test
BACKGROUND: We aimed to derive an algorithm to define the optimal proportion of patients with mild cognitive impairment (MCI) in whom cerebrospinal fluid (CSF) testing is of added prognostic value. METHODS: MCI patients were selected from the Amsterdam Dementia Cohort (n = 402). Three-year progressi...
Salvato in:
| Pubblicato in: | Alzheimers Res Ther |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792312/ https://ncbi.nlm.nih.gov/pubmed/33413634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00763-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|